Default company panoramic image

Genetix Fusion

Genetix Fusion is a biotechnology company introducing the next-generation of non-toxic & efficient transfection kit for academic researchers

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location St. Louis, MO, USA
  • Currency USD
  • Founded September 2012
  • Employees 2
  • Website

Company Summary

Genetix Fusion LLC is a biotechnology company that offers a superior and unique Janus transfection kits for scientists. Transfection is the process of transferring nucleic acids (DNA, RNA) into cells. Our products use new class of small chemical molecules and methods to efficiently and safely transfect cells, at a lower cost than competing products, thus saving valuable time and resources for scientific researchers.


  • Default avatar
    Jason L. Atkins

    Jason L. Atkins has acquired a M.Sc. Biochemistry and Biotechnology from University of Missouri St. Louis and has won numerous academic and research awards. He is the co-inventor of the technology and co-founder of Genetix Fusion. Atkins is currently working on launch of beta prototype of the Janus Transfection Kit, acquiring prototype feedback, development of PCT/Utility patent applications and development of other applications for the technolog

  • Default avatar
    Mohit B. Patel
    Executive Vice President/Business Development

    Mohit B. Patel has acquired M. Sc. Biochemistry & Biotechnology with academic awards and publications. Patel has represented Genetix Fusion at the Olin Cup Business Plan competition, Texas Life Science Venture Forum and Bio-Entrepreneur Development program at the Center for Emerging Technologies. Patel is involved in the acquisition of an enterprise licensing agreement (ELA), establishing operations, and raising seed stage funding.

  • Default avatar
    George W. Gokel
    Scientific Advisor

    George W. Gokel, PhD is a distinguished professor of sciences and director of Center for Nano-science at University of Missouri St. Louis. He is an expert in chemical synthesis with more than 40 years of experience15 issued patents and more than 400 publications. He is co-inventor of the technology and will provide scientific advice for development of Janus transfection kits and future product line.

  • Default avatar
    Matthew R. MacEwan
    Business Advisor

    Matthew R. MacEwan is President/CSO of Retectix, LLC, successful entreprenueur & recipient of numerous entrepreneurial awards including LES, Olin Cup Competition, Idea to product & St. Louis ’40 under 40’. He provides advice on corporate strategy and business development for Genetix Fusion.